Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
23.00    0.00 (0.00%)
Bid:
22.00
Ask:
24.00
Spread: 2.00 (9.091%)
Market Cap: £24.84m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Derivative Claim - Further Update

28 Jan 2015 12:45

RNS Number : 3884D
Elektron Technology PLC
28 January 2015
 



28 January 2015

 

Elektron Technology plc

(AIM: EKT, "Elektron" or "the Company" or the "Group")

 

Derivative Claim - Further Update

 

In its 2014 Annual Report the Company disclosed derivative litigation brought by a shareholder, Mr Bridge, who holds at the date of this announcement 1.83 % of the Company's ordinary shares.

 

As reported by the Company in its update on 2 October 2014, at the last hearing on 1 October 2014 the Court made an Order ("the Order") giving directions for the management of the claim and for a further directions hearing ("the hearing") to take place. That hearing was held on 26 January 2015 in the High Court in London.

 

Mr Bridge did not attend the hearing. Legal representatives of the Company and of the directors did attend the hearing.

 

At the hearing the Court recorded that:

 

i. Mr Bridge had not sought to engage in discussions to enable the parties to consider alternative dispute resolution, as provided in the Order;

ii. Mr Bridge had not chosen to serve any amended Particulars of Claim within the time period prescribed by the Order;

iii. Mr Bridge had not sought to agree directions, as required by the Order, to enable the proceedings to get swiftly to a hearing at which the Court could determine whether the claim against the directors should be allowed to continue; and

iv. Mr Bridge had not produced any sufficient reason for not attending the hearing of 26 January 2015, at least by telephone (as the Company had indicated to him was a possibility).

The Judge noted that Mr Bridge's conduct in the run-up to the hearing bore all the hallmarks of the opportunistic and tactical approach that he had found permeated Mr Bridge's conduct before the 1 October 2014 hearing. 

The resulting Order from the hearing was:

 

1. The Defendants be given permission to file and serve updating evidence limited to the performance of the Company and the attitude of the Company's non-party Directors to Mr Bridge's derivative claim;

2. No further evidence be permitted without the prior permission of the Court;

3. The hearing of the adjourned application for permission to continue the claim to take place on 16 and 17 June 2015 in the High Court in Liverpool; and

4. The Court made clear that it would consider whether Mr Bridge should be entitled to an indemnity for his costs of the proceedings from the Company (an order that he is seeking) after, and if, the Court gives permission for the action to continue.

Further updates will be provided in due course.

 

Enquiries:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

Andy Weatherstone - Chief Financial Officer

Martin Reeves - Company Secretary

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Kay Larsen

 

Notes to Editors 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas: 

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition it owns a portfolio of well-established products and brands which provide customer access and feedback. 

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange. 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURPKFDBBBKDFDB
Date   Source Headline
9th Apr 20268:04 amEQSForm 8.3 - Checkit PLC
8th Apr 202612:51 pmRNSForm 8.3 - Checkit PLC
8th Apr 202612:48 pmRNSHolding(s) in Company
8th Apr 20269:54 amRNSForm 8.5 (EPT/RI)
7th Apr 202611:44 amRNSForm 8.3 - Checkit plc
7th Apr 202610:30 amRNSForm 8.5 (EPT/RI)
1st Apr 202610:37 amRNSForm 8.5 (EPT/RI)
1st Apr 20269:38 amRNSForm 8.3 - Checkit PLC
1st Apr 20267:47 amRNSForm 8 (OPD) - Checkit plc
31st Mar 20262:50 pmEQSForm 8.3 - Checkit PLC
31st Mar 202611:29 amRNSForm 8.3 - Checkit plc
31st Mar 202611:12 amRNSHolding(s) in Company
31st Mar 202610:51 amRNSForm 8.5 (EPT/RI)
30th Mar 20261:58 pmRNSForm 8.3 - Checkit plc
30th Mar 202610:14 amRNSForm 8.5 (EPT/RI)
27th Mar 20263:39 pmRNSForm 8.3 Check it
27th Mar 20262:43 pmRNSForm 8.3 - Checkit PLC
27th Mar 202611:44 amRNSForm 8.3 - Checkit plc
27th Mar 202611:36 amEQSForm 8.3 - Checkit PLC
27th Mar 202610:40 amRNSForm 8.5 (EPT/RI)
27th Mar 202610:32 amRNSCheckit Plc - Form 8.3
26th Mar 202610:26 amRNSForm 8.3 - Checkit PLC
26th Mar 20267:45 amRNSDisclosure Table
26th Mar 20267:00 amRNSCommencement of Formal Sale Process
19th Feb 20267:00 amRNSFY26 Trading Update
21st Jan 202611:34 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
30th Oct 20251:00 pmRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
13th Oct 20252:52 pmRNSGrant of options and PDMR dealing
25th Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSInterim Results
19th Jun 20252:36 pmRNSGrant of Options
5th Jun 20253:11 pmRNSResult of AGM
29th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSFinal Results
17th Apr 20257:00 amRNSNotice of Results and Investor Presentation
8th Apr 20257:00 amRNSStrategic update
20th Mar 202512:31 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:21 amRNSForm 8.5 (EPT/RI)
19th Mar 202512:02 pmRNSResult of General Meeting
18th Mar 20259:43 amRNSForm 8.5 (EPT/RI)
18th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.